Early research (Phase 1)Ended earlyNCT01288430What this trial is testingDS-2248 in Participants With Advanced Solid TumorsWho this might be right forSolid TumorsNon-small Cell Lung Carcinoma Daiichi Sankyo 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT04958811What this trial is testingTiragolumab With Atezolizumab Plus Bevacizumab in Previously-Treated Advanced Non-squamous NSCLCWho this might be right forNon-squamous Non-small-cell Lung Cancer Georgetown University 29
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07710612What this trial is testingABSK043 Combined With OsimertinibWho this might be right forNon-Small Cell Lung Cancer With EGFR-mutated and PD-L1 Positive Abbisko Therapeutics Co, Ltd 72
Testing effectiveness (Phase 2)Study completedNCT03977467What this trial is testingAtezolizumab and Tiragolumab in Patients With NSCLC or Advanced Solid Tumors Having Had Prior Treatment With a PD-1 InhibitorWho this might be right forNon-Small Cell Lung CancerSolid Tumor SCRI Development Innovations, LLC 46
Not applicableLooking for participantsNCT07086300What this trial is testingElectroacupuncture Combined With PD-1 Inhibitor for Elderly Patients With Advanced NSCLCWho this might be right forElderly Patients (>65 Years)Non-Small Cell Lung CancerPD-1 Inhibitors+1 more Kong Fanming 120
Testing effectiveness (Phase 2)Study completedNCT00081107What this trial is testingEpothilone D in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Has Not Responded to Platinum-Based ChemotherapyWho this might be right forLung Cancer Memorial Sloan Kettering Cancer Center
Not applicableNo Longer AvailableNCT03178071What this trial is testingExpanded Access For Lorlatinib For Patients With Non Small Cell Lung Cancer ALK Positive or ROS1 PositiveWho this might be right forNon Small Cell Lung Cancer ALK Positive or ROS1 Positive Pfizer
Testing effectiveness (Phase 2)Active Not RecruitingNCT06114511What this trial is testingBL-M07D1 in Patients With HER2-Overexpressing or HER2-Mutant Locally Advanced or Metastatic Non-Small Cell Lung CancerWho this might be right forNon-small Cell Lung Cancer Sichuan Baili Pharmaceutical Co., Ltd. 78
Testing effectiveness (Phase 2)Study completedNCT01750281What this trial is testingAssess Efficacy and Safety of AZD6244 in Combination With Docetaxel in Patients Receiving Second Line Non Small Cell Lung Cancer Treatment.Who this might be right forLocally Advanced or Metastatic Non Small Cell Lung Cancer Stage IIIb - IV AstraZeneca 212
Testing effectiveness (Phase 2)Active Not RecruitingNCT05853575What this trial is testingTrial of Two Adagrasib Dosing Regimens in NSCLC With KRAS G12C Mutation (KRYSTAL 21)Who this might be right forAdvanced CancerMetastatic CancerMalignant Neoplasm of Lung Mirati Therapeutics Inc. 200
Early research (Phase 1)UnknownNCT03050411What this trial is testingApatinib Combine With EGFR-TKI for Advanced EGFR-TKI-resistant Non-Small Cell Lung CancerWho this might be right forNonsmall Cell Lung Cancer Peking University Third Hospital 30
Testing effectiveness (Phase 2)WithdrawnNCT03684967What this trial is testingStudy of Fruquintinib (HMPL-013) in High Risk Patients With Advanced NSCLCWho this might be right forLung Cancer Hutchison Medipharma Limited
Large-scale testing (Phase 3)Study completedNCT01631136What this trial is testingStrategies for Maintenance Therapies in Advanced Non Small Cell Lung CancerWho this might be right forAdvanced Non Small Cell Lung Cancer Intergroupe Francophone de Cancerologie Thoracique 932
Testing effectiveness (Phase 2)Ended earlyNCT00783471What this trial is testingDocetaxel Intermittent-Erlotinib (Tarceva®) In Metastatic Non Small Cell Lung Cancer (NSCLC)Who this might be right forAdvanced Non-Small Cell Lung Cancer Hellenic Cooperative Oncology Group 51
Testing effectiveness (Phase 2)Study completedNCT04647344What this trial is testingAK104 in Patients With Locally Advanced or Metastatic Non-small Cell Lung CancerWho this might be right forLung Cancer Non-Small Cell Stage IIIB/IIIC/IV Akeso 46
Not applicableApproved For MarketingNCT04829422What this trial is testingEarly Access Program of Lazertinib in Republic of KoreaWho this might be right forLung Cancer Yuhan Corporation
Testing effectiveness (Phase 2)UnknownNCT05900219What this trial is testingEfficacy and Safety of HL-085 Combined With Vemurafenib in BRAF V600E Patients With Non-small Cell Lung Cancer: a Phase II Clinical StudyWho this might be right forNon-small-cell Lung Cancer Shanghai Kechow Pharma, Inc. 75
Large-scale testing (Phase 3)Looking for participantsNCT05085028What this trial is testingA Randomised Open-label Phase III Trial of REduced Frequency Pembrolizumab immuNothErapy for First-line Treatment of Patients With Advanced Non-small Cell Lung Cancer (NSCLC)Who this might be right forLung Cancer, Nonsmall Cell Imperial College London 1,750
Early research (Phase 1)Looking for participantsNCT05948865What this trial is testingCPO301 in Adult Patients With Advanced or Metastatic Solid TumorsWho this might be right forCancerCancer, Lung Conjupro Biotherapeutics, Inc. 132
Early research (Phase 1)Not Yet RecruitingNCT07558200What this trial is testingPhase Ia/Ib Study of FXB0871 Monotherapy in Locally Advanced/Metastatic Solid TumorsWho this might be right forSolid TumorsNon-Small Cell Lung CancerHepatocellular Carcinoma Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. 138